Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
J Med Virol ; 95(5): e28786, 2023 05.
Article in English | MEDLINE | ID: covidwho-2323697

ABSTRACT

The aim of this study was to analyze whether the coronavirus disease 2019 (COVID-19) vaccine reduces mortality in patients with moderate or severe COVID-19 disease requiring oxygen therapy. A retrospective cohort study, with data from 148 hospitals in both Spain (111 hospitals) and Argentina (37 hospitals), was conducted. We evaluated hospitalized patients for COVID-19 older than 18 years with oxygen requirements. Vaccine protection against death was assessed through a multivariable logistic regression and propensity score matching. We also performed a subgroup analysis according to vaccine type. The adjusted model was used to determine the population attributable risk. Between January 2020 and May 2022, we evaluated 21,479 COVID-19 hospitalized patients with oxygen requirements. Of these, 338 (1.5%) patients received a single dose of the COVID-19 vaccine and 379 (1.8%) were fully vaccinated. In vaccinated patients, mortality was 20.9% (95% confidence interval [CI]: 17.9-24), compared to 19.5% (95% CI: 19-20) in unvaccinated patients, resulting in a crude odds ratio (OR) of 1.07 (95% CI: 0.89-1.29; p = 0.41). However, after considering the multiple comorbidities in the vaccinated group, the adjusted OR was 0.73 (95% CI: 0.56-0.95; p = 0.02) with a population attributable risk reduction of 4.3% (95% CI: 1-5). The higher risk reduction for mortality was with messenger RNA (mRNA) BNT162b2 (Pfizer) (OR 0.37; 95% CI: 0.23-0.59; p < 0.01), ChAdOx1 nCoV-19 (AstraZeneca) (OR 0.42; 95% CI: 0.20-0.86; p = 0.02), and mRNA-1273 (Moderna) (OR 0.68; 95% CI: 0.41-1.12; p = 0.13), and lower with Gam-COVID-Vac (Sputnik) (OR 0.93; 95% CI: 0.6-1.45; p = 0.76). COVID-19 vaccines significantly reduce the probability of death in patients suffering from a moderate or severe disease (oxygen therapy).


Subject(s)
COVID-19 , Vaccines , Humans , COVID-19 Vaccines , Oxygen , ChAdOx1 nCoV-19 , BNT162 Vaccine , Cohort Studies , Retrospective Studies , COVID-19/prevention & control , RNA, Messenger
2.
Viruses ; 15(4)2023 04 09.
Article in English | MEDLINE | ID: covidwho-2298322

ABSTRACT

A wide range of human respiratory viruses are known that may cause acute respiratory infections (ARIs), such as influenza A and B viruses (HIFV), respiratory syncytial virus (HRSV), coronavirus (HCoV), parainfluenza virus (HPIV), metapneumovirus (HMPV), rhinovirus (HRV), adenovirus (HAdV), bocavirus (HBoV), and others. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COronaVIrus Disease (COVID) that lead to pandemic in 2019 and significantly impacted on the circulation of ARIs. The aim of this study was to analyze the changes in the epidemic patterns of common respiratory viruses among children and adolescents hospitalized with ARIs in hospitals in Novosibirsk, Russia, from November 2019 to April 2022. During 2019 and 2022, nasal and throat swabs were taken from a total of 3190 hospitalized patients 0-17 years old for testing for HIFV, HRSV, HCoV, HPIV, HMPV, HRV, HAdV, HBoV, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time PCR. The SARS-CoV-2 virus dramatically influenced the etiology of acute respiratory infections among children and adolescents between 2019 and 2022. We observed dramatic changes in the prevalence of major respiratory viruses over three epidemic research seasons: HIFV, HRSV, and HPIV mainly circulated in 2019-2020; HMPV, HRV, and HCoV dominated in 2020-2021; and HRSV, SARS-CoV-2, HIFV, and HRV were the most numerous agents in 2021-2022. Interesting to note was the absence of HIFV and a significant reduction in HRSV during the 2020-2021 period, while HMPV was absent and there was a significant reduction of HCoV during the following epidemic period in 2021-2022. Viral co-infection was significantly more frequently detected in the 2020-2021 period compared with the other two epidemic seasons. Certain respiratory viruses, HCoV, HPIV, HBoV, HRV, and HAdV, were registered most often in co-infections. This cohort study has revealed that during the pre-pandemic and pandemic periods, there were dramatic fluctuations in common respiratory viruses registered among hospitalized patients 0-17 years old. The most dominant virus in each research period differed: HIFV in 2019-2020, HMPV in 2020-2021, and HRSV in 2021-2022. Virus-virus interaction was found to be possible between SARS-CoV-2 and HRV, HRSV, HAdV, HMPV, and HPIV. An increase in the incidence of COVID-19 was noted only during the third epidemic season (January to March 2022).


Subject(s)
COVID-19 , Respiratory Syncytial Virus, Human , Respiratory Tract Infections , Virus Diseases , Viruses , Adolescent , Humans , Child , Infant , Infant, Newborn , Child, Preschool , SARS-CoV-2 , Cohort Studies , COVID-19/epidemiology , Respiratory Tract Infections/epidemiology
3.
2022 IEEE International Conference on Blockchain, Smart Healthcare and Emerging Technologies, SmartBlock4Health 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2261854

ABSTRACT

The covid-19 pandemic brought the need to reduce human interaction so in order to facilitate the interaction with the doctors but reduce unnecessary trips to a medical specialty, and have a better understanding of the investigation result, we present our approach of a medical test interpreter, integrated with a symptom checker. Our system aims to provide a temporary solution for diagnostic a condition until the patient reaches a doctor, so a proper diagnose can be made. This system can also be used in low-income countries were access to healthcare is limited and people discover diseases too late. © 2022 IEEE.

4.
Research in Psychotherapy: Psychopathology, Process and Outcome ; 25(Supplement 1):33-34, 2022.
Article in English | EMBASE | ID: covidwho-2264158

ABSTRACT

Introduction: Online group psychotherapy has only recently been developed in Italy due to the health emergency. Due to the restrictions, group therapists have dealt the transition from face-to-face to online setting, learning from experience how to manage the clinical relationship mediated by the screen. In particular, the management of the setting, group interactions and the therapeutic style. Method(s):The present study is based on a survey that involved 26 group therapists who agreed to participate and answered the survey during the first three months after the shifting to online practice. The sample was mainly composed of women (67%), with an average age of 55 years and professional experience between 20 and 40 years;the work area was equally distributed between north, central and southern Italy;the participants' career orientation was almost exclusively psychodynamic / psychoanalytic (86%) and the groups were analytic in the private setting, with two exceptions in a public service. The survey was structured in two sections: the first relating to individual online therapy was organized through 4 main areas: (i) the changes in the use of online intervention due to Covid-19;(ii) the virtual set (tting);(iii) the perception of the therapeutic relationship mediated by the screen;(iv) corporeality in the online therapeutic relationship. The second section dealt specifically with online group psychotherapy and explored questions such as the comparison between face-toface and online groups in terms of efficacy, therapeutic factors, interplay and interactions among group participants and challenges in leading online group. Responses were provided on a likert scale, but in many questions the therapist were required to motivate and argue their thought. Data were analyzed through mixed method, occurrence and percentage of the responses were counted and calcu- lated, while through a qualitative analysis the contents were extrapolated from the answers provided by the therapists. Result(s): Results show that the therapists have experienced with difficulty the management of the online setting and finding their most challenging task in three areas: interpersonal relationship, the loss of feelings, and the therapeutic presence. More in general, results gave us an overall picture of how therapists perceived and represent themselves the online group psychotherapy. In their view group online are characterized by the absence of the body (or rather of the body communication), the modification of the perception of emotions, the loss of directionality and reciprocity of the gaze, the alteration of temporality in the online and the changes with respect to the therapeutic presence of the clinician during the session. Moreover, therapists reported the necessity to spend greater resources in online setting, resource in terms of attention, concentration, fatigue, and also to deal with one's own and others' sources of environmental distraction. In line with these perceptions, the majority of therapists reported the need to be more active and more directive in leading the group, as well as the need to maintain control and manage silence, the latter was in effect considered more difficult to manage in the online mode. Conclusion(s): Overall, the results of our survey suggest that there has been a good ability to adapt to the online setting. At the same time, the prevailing representation is that online therapy has quite different characteristics. It also seems that forcing the use of the online setting has diminished the distrust towards this type of therapy. Of course, the small number of therapists involved in the survey does not allow the responses to be considered as representative and limits the possibility of generalizing the Results: It is also important to consider the results in light of the particular situation caused by the pandemic, this leads to the recognition that many issues relating to online therapy are still "open questions" and must therefore be the subject of new research and reflections. Further research, already un ertaken in recent months, will also have to deepen the patients' experience, with respect to their experiences, the differences they found between the two settings, the functioning of the online group, their perception of the main processes and therapeutic factors.

5.
Pharmaceutics ; 15(3)2023 Mar 16.
Article in English | MEDLINE | ID: covidwho-2283203

ABSTRACT

It has recently been shown that the titer of the SARS-CoV-2 virus decreases in a cell culture when the cell suspension is irradiated with electromagnetic waves at a frequency of 95 GHz. We assumed that a frequency range in the gigahertz and sub-terahertz ranges was one of the key aspects in the "tuning" of flickering dipoles in the dispersion interaction process of the surfaces of supramolecular structures. To verify this assumption, the intrinsic thermal radio emission in the gigahertz range of the following nanoparticles was studied: virus-like particles (VLP) of SARS-CoV-2 and rotavirus A, monoclonal antibodies to various RBD epitopes of SARS-CoV-2, interferon-α, antibodies to interferon-γ, humic-fulvic acids, and silver proteinate. At 37 °C or when activated by light with λ = 412 nm, these particles all demonstrated an increased (by two orders of magnitude compared to the background) level of electromagnetic radiation in the microwave range. The thermal radio emission flux density specifically depended on the type of nanoparticles, their concentration, and the method of their activation. The thermal radio emission flux density was capable of reaching 20 µW/(m2 sr). The thermal radio emission significantly exceeded the background only for nanoparticles with a complex surface shape (nonconvex polyhedra), while the thermal radio emission from spherical nanoparticles (latex spheres, serum albumin, and micelles) did not differ from the background. The spectral range of the emission apparently exceeded the frequencies of the Ka band (above 30 GHz). It was assumed that the complex shape of the nanoparticles contributed to the formation of temporary dipoles which, at a distance of up to 100 nm and due to the formation of an ultrahigh strength field, led to the formation of plasma-like surface regions that acted as emitters in the millimeter range. Such a mechanism makes it possible to explain many phenomena of the biological activity of nanoparticles, including the antibacterial properties of surfaces.

6.
medrxiv; 2023.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2023.02.27.23286488

ABSTRACT

Introduction. There is no unequivocal opinion concerning the influence of decreased liver attenuation on the COVID-19 severity, but its widespread occurrence among these patients has been shown. There has been no evaluation of the liver status both before and after COVID-19. Study objective. To assess the prognostic value of liver attenuation on CT scan in patients with COVID-19. Material and methods. A retrospective cohort study. Data of COVID-19 outpatients were analyzed. Inclusion criteria: two chest CT scans, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in blood, and polymerase chain reaction results to verify SARS-CoV-2. Subjects were categorized into four comparison groups depending on the severity of lung involvement. Liver attenuation was analyzed by automatic segmentation, where the values less than 40 HU were considered pathological. Results. Data from 499 subjects were included. The groups differed in age and the level of liver attenuation on both CT scans. No correlation between ALT, AST and changes in liver attenuation was found. On follow-up CT, low liver attenuation was observed in males (odds ratio (OR) 2.79 (95% CI 1.42-5.47), p-value = 0.003) and in patients with a baseline reduced liver density (OR 60.59 (95% CI 30.51-120.33), p-value < 0.001). Age over 60 years was associated with the development of lung lesions (OR 1.04 (95% CI 1.02-1.06) for extent of lung injury < 25%, OR 1.08 (95% CI 1.05-1.11) for 25-50%, OR 1.1 (95% CI 1.06-1.15) for 25-50%, p-value < 0.001). Low liver attenuation on the baseline CT scan increased the odds of severe lung injury (OR 6.9 (95% CI 2.06-23.07), p-value = 0.002). Conclusion. In COVID-19, patients with low liver attenuation are more likely to develop severe lung damage.


Subject(s)
Lung Diseases , COVID-19
7.
Revista espanola de salud publica ; 97:e202302010, 2023.
Article in Spanish | Europe PMC | ID: covidwho-2240668

ABSTRACT

SARS-CoV-2 infection was an unprecedented pandemic with unprecedented global health and socio-economic impact. More than 13 million cases had been confirmed in Spain by August 2022, and diagnostic testing to detect cases of infection in the country has helped to partially mitigate the spread of the virus. In 2021, the first self-testing antigen tests were marketed for dispensing in community pharmacies, and over-the-counter dispensing was allowed from July of that year. The network of community pharmacies played a key role, not only in the informed dispensing of these tests, but also in actively participating in the performance, supervision and reporting of results to the health authorities, and even in the issuing of digital certificates. A compilation has been made of all the available data on the subject, with a deadline of 13 February 2022, which is considered to be the end of the sixth wave of the epidemic in Spain. The results of the action taken by community pharmacies in twelve Autonomous Communities, which somehow participated in these initiatives by carrying out or supervising a total of 1,043,800 tests, from which 109,570 positive cases (10.5% of the total) were detected and reported to the National Health System, are presented in this article. Although the results are provisional, because many of the programmes are still ongoing, they are a clear demonstration of the potential that community pharmacies can play in Public Health work.

8.
Int J Mol Sci ; 24(1)2022 Dec 27.
Article in English | MEDLINE | ID: covidwho-2242276

ABSTRACT

The clinical course of the new coronavirus disease 2019 (COVID-19) has shown that patients with chronic lymphocytic leukemia (CLL) are characterized by a high mortality rate, poor response to standard treatment, and low virus-specific antibody response after recovery and/or vaccination. To date, there are no data on the safety and efficacy of the combined vector vaccine Sputnik V in patients with CLL. Here, we analyzed and compared the magnitudes of the antibody and T cell responses after vaccination with the Sputnik V vaccine among healthy donors and individuals with CLL with different statuses of preexposure to coronavirus. We found that vaccination of the COVID-19-recovered individuals resulted in the boosting of pre-existing immune responses in both healthy donors and CLL patients. However, the COVID-19-naïve CLL patients demonstrated a considerably lower antibody response than the healthy donors, although they developed a robust T cell response. Regardless of the previous infection, the individuals over 70 years old demonstrated a decreased response to vaccination, as did those receiving anti-CD20 therapy. In summary, we showed that Sputnik V, like other vaccines, did not induce a robust antibody response in individuals with CLL; however, it provided for the development of a significant anti-COVID-19 T cell response.


Subject(s)
COVID-19 Vaccines , COVID-19 , Leukemia, Lymphocytic, Chronic, B-Cell , Aged , Humans , Antibodies, Viral , COVID-19/prevention & control , T-Lymphocytes , Vaccination , Vaccines, Combined , COVID-19 Vaccines/immunology , Vaccines, Synthetic
9.
Sci Rep ; 13(1): 2306, 2023 02 09.
Article in English | MEDLINE | ID: covidwho-2234489

ABSTRACT

Coronaviruses (CoVs) pose a huge threat to public health as emerging viruses. Bat-borne CoVs are especially unpredictable in their evolution due to some unique features of bat physiology boosting the rate of mutations in CoVs, which is already high by itself compared to other viruses. Among bats, a meta-analysis of overall CoVs epizootiology identified a nucleic acid observed prevalence of 9.8% (95% CI 8.7-10.9%). The main objectives of our study were to conduct a qPCR screening of CoVs' prevalence in the insectivorous bat population of Fore-Caucasus and perform their characterization based on the metagenomic NGS of samples with detected CoV RNA. According to the qPCR screening, CoV RNA was detected in 5 samples, resulting in a 3.33% (95% CI 1.1-7.6%) prevalence of CoVs in bats from these studied locations. BetaCoVs reads were identified in raw metagenomic NGS data, however, detailed characterization was not possible due to relatively low RNA concentration in samples. Our results correspond to other studies, although a lower prevalence in qPCR studies was observed compared to other regions and countries. Further studies should require deeper metagenomic NGS investigation, as a supplementary method, which will allow detailed CoV characterization.


Subject(s)
Chiroptera , Coronavirus Infections , Coronavirus , Animals , Coronavirus/genetics , Coronavirus Infections/epidemiology , Coronavirus Infections/veterinary , Coronavirus Infections/genetics , Genome, Viral , Phylogeny , RNA
11.
MMWR Morb Mortal Wkly Rep ; 71(17): 592-596, 2022 Apr 29.
Article in English | MEDLINE | ID: covidwho-2204198

ABSTRACT

On August 29, 2021, the United States government oversaw the emergent establishment of Operation Allies Welcome (OAW), led by the U.S. Department of Homeland Security (DHS) and implemented by the U.S. Department of Defense (DoD) and U.S. Department of State (DoS), to safely resettle U.S. citizens and Afghan nationals from Afghanistan to the United States. Evacuees were temporarily housed at several overseas locations in Europe and Asia* before being transported via military and charter flights through two U.S. international airports, and onward to eight U.S. military bases,† with hotel A used for isolation and quarantine of persons with or exposed to certain infectious diseases.§ On August 30, CDC issued an Epi-X notice encouraging public health officials to maintain vigilance for measles among Afghan evacuees because of an ongoing measles outbreak in Afghanistan (25,988 clinical cases reported nationwide during January-November 2021) (1) and low routine measles vaccination coverage (66% and 43% for the first and second doses, respectively, in 2020) (2).


Subject(s)
Communicable Diseases , Measles , Communicable Diseases/epidemiology , Disease Outbreaks/prevention & control , Humans , Measles/epidemiology , Measles/prevention & control , Public Health , United States/epidemiology , Vaccination
12.
Frontiers in physiology ; 13, 2022.
Article in English | EuropePMC | ID: covidwho-2046585

ABSTRACT

Over the past 40 years, psychological support (PS) for cosmonauts and astronauts has remained an important part of the regular biomedical provision of space crews during extended orbital flights. It includes well-developed principles and a set of methods that have proven its effectiveness for the maintenance of behavioral health under extreme conditions of space flight. The main principle of PS in flight is to restore the usual sensory input to compensate for the monotony and lack of external stimuli as a result of a long stay under isolation and confinement. Risk factors for the psychological health and well-being defined for the astronauts, such as sensory and social deprivation, monotony, confinement, and lack of privacy, also remain part and parcel of several civil professions. These include polar wintering, submarines, working on oil platforms, and ocean fishing. Most of these factors also adversely affect the recovery rate of a large contingent of medical institutions, especially bedridden patients with chronic diseases. Finally, due to the negative epidemiological situation associated with the spread of COVID-19, an increasingly wide range of citizens forced to be in self-isolation faces negative manifestations of the deprivation phenomena described previously. Several cases of successful use of PS under isolation, monotony, crowding, and confinement are presented. Thus, we assume that the use of psychological support methods developed for space flights could be extremely relevant in civil medicine and everyday life.

14.
Beilstein J Nanotechnol ; 13: 699-711, 2022.
Article in English | MEDLINE | ID: covidwho-1979460

ABSTRACT

The novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently one of the most contagious viruses in existence and the cause of the worst pandemic in this century, COVID-19. SARS-CoV-2 infection begins with the recognition of the cellular receptor angiotensin converting enzyme-2 by its spike glycoprotein receptor-binding domain (RBD). Thus, the use of small peptides to neutralize the infective mechanism of SARS-CoV-2 through the RBD is an interesting strategy. The binding ability of 104 peptides (University of Nebraska Medical Center's Antimicrobial Peptide Database) to the RBD was assessed using molecular docking. Based on the molecular docking results, peptides with great affinity to the RBD were selected. The most common amino acids involved in the recognition of the RBD were identified to design novel peptides based on the number of hydrogen bonds that were formed. At physiological pH, these peptides are almost neutral and soluble in aqueous media. Interestingly, several peptides showed the capability to bind to the active surface area of the RBD of the Wuhan strain, as well as to the RBD of the Delta variant and other SARS-Cov-2 variants. Therefore, these peptides have promising potential in the treatment of the COVID-19 disease caused by different variants of SARS-CoV-2. This research work will be focused on the molecular docking of peptides by molecular dynamics, in addition to an analysis of the possible interaction of these peptides with physiological proteins. This methodology could be extended to design peptides that are active against other viruses.

15.
arxiv; 2022.
Preprint in English | PREPRINT-ARXIV | ID: ppzbmed-2207.07689v1

ABSTRACT

Currently, the evolution of Covid-19 allows researchers to gather the datasets accumulated over 2 years and to use them in predictive analysis. In turn, this makes it possible to assess the efficiency potential of more complex predictive models, including neural networks with different forecast horizons. In this paper, we present the results of a consistent comparative study of different types of methods for predicting the dynamics of the spread of Covid-19 based on regional data for two countries: the United States and Russia. We used well-known statistical methods (e.g., Exponential Smoothing), a "tomorrow-as-today" approach, as well as a set of classic machine learning models trained on data from individual regions. Along with them, a neural network model based on Long short-term memory (LSTM) layers was considered, the training samples of which aggregate data from all regions of two countries: the United States and Russia. Efficiency evaluation was carried out using cross-validation according to the MAPE metric. It is shown that for complicated periods characterized by a large increase in the number of confirmed daily cases, the best results are shown by the LSTM model trained on all regions of both countries, showing an average Mean Absolute Percentage Error (MAPE) of 18%, 30%, 37% for Russia and 31%, 41%, 50% for US for predictions at forecast horizons of 14, 28, and 42 days, respectively.


Subject(s)
COVID-19
16.
Clin Infect Dis ; 75(1): e1-e9, 2022 08 24.
Article in English | MEDLINE | ID: covidwho-1886385

ABSTRACT

BACKGROUND: During the ongoing coronavirus disease 2019 (COVID-19) pandemic, many individuals were infected with and have cleared the virus, developing virus-specific antibodies and effector/memory T cells. An important unanswered question is what levels of T-cell and antibody responses are sufficient to protect from the infection. METHODS: In 5340 Moscow residents, we evaluated anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin M (IgM)/immunoglobulin G (IgG) titers and frequencies of the T cells specific to the membrane, nucleocapsid, and spike proteins of SARS-CoV-2, using interferon gamma (IFN-γ) enzyme-linked immunosorbent spot (ELISpot) assay. Additionally, we evaluated the fractions of virus-specific CD4+ and CD8+ T cells using intracellular staining of IFN-γ and interleukin 2 followed by flow cytometry. We analyzed the COVID-19 rates as a function of the assessed antibody and T-cell responses, using the Kaplan-Meier estimator method, for up to 300 days postinclusion. RESULTS: We showed that T-cell and antibody responses are closely interconnected and are commonly induced concurrently. Magnitudes of both responses inversely correlated with infection probability. Individuals positive for both responses demonstrated the highest levels of protectivity against the SARS-CoV-2 infection. A comparable level of protection was found in individuals with antibody response only, whereas the T-cell response by itself granted only intermediate protection. CONCLUSIONS: We found that the contribution of the virus-specific antibodies to protection against SARS-CoV-2 infection is more pronounced than that of the T cells. The data on the virus-specific IgG titers may be instructive for making decisions in personalized healthcare and public anti-COVID-19 policies. Clinical Trials Registration. NCT04898140.


Subject(s)
COVID-19 , SARS-CoV-2 , Antibodies, Viral , Humans , Immunoglobulin G , Prospective Studies
17.
Mathematics ; 10(11):1925, 2022.
Article in English | MDPI | ID: covidwho-1884263

ABSTRACT

Patients with COVID-19 can develop pneumonia, severe symptoms of acute respiratory distress syndrome, and multiple organ failure. Nevertheless, the variety of forms of this disease requires further research on the pathogenesis of this disease. Based on the analysis of published data and original experiments on the concentrations of SARS-CoV-2 in biological fluids of the nasopharynx, lungs, and intestines and using a developed modular model of the virus distribution in human tissue and organs, an assessment of the SARS-CoV-2 reproduction in various compartments of the body is presented. Most of the viral particles can transport to the esophagus from the nasopharynx. The viral particles entering the gastrointestinal tract will obviously be accompanied by the infection of the intestinal epithelium and accumulation of the virus in the intestinal lumen in an amount proportional to their secretory and protein-synthetic activities. The relatively low concentration of SARS-CoV-2 in tissues implies an essential role of transport processes and redistribution of the virus from the nasopharynx and intestines to the lungs. The model simulations also suppose that sanitation of the nasopharynx mucosa at the initial stage of the infectious process has prospects for the use in medical practice.

18.
Elife ; 112022 05 17.
Article in English | MEDLINE | ID: covidwho-1847655

ABSTRACT

New SARS-CoV-2 variants, breakthrough infections, waning immunity, and sub-optimal vaccination rates account for surges of hospitalizations and deaths. There is an urgent need for clinically valuable and generalizable triage tools assisting the allocation of hospital resources, particularly in resource-limited countries. We developed and validate CODOP, a machine learning-based tool for predicting the clinical outcome of hospitalized COVID-19 patients. CODOP was trained, tested and validated with six cohorts encompassing 29223 COVID-19 patients from more than 150 hospitals in Spain, the USA and Latin America during 2020-22. CODOP uses 12 clinical parameters commonly measured at hospital admission for reaching high discriminative ability up to 9 days before clinical resolution (AUROC: 0·90-0·96), it is well calibrated, and it enables an effective dynamic risk stratification during hospitalization. Furthermore, CODOP maintains its predictive ability independently of the virus variant and the vaccination status. To reckon with the fluctuating pressure levels in hospitals during the pandemic, we offer two online CODOP calculators, suited for undertriage or overtriage scenarios, validated with a cohort of patients from 42 hospitals in three Latin American countries (78-100% sensitivity and 89-97% specificity). The performance of CODOP in heterogeneous and geographically disperse patient cohorts and the easiness of use strongly suggest its clinical utility, particularly in resource-limited countries.


While COVID-19 vaccines have saved millions of lives, new variants, waxing immunity, unequal rollout and relaxation of mitigation strategies mean that the pandemic will keep on sending shockwaves across healthcare systems. In this context, it is crucial to equip clinicians with tools to triage COVID-19 patients and forecast who will experience the worst forms of the disease. Prediction models based on artificial intelligence could help in this effort, but the task is not straightforward. Indeed, the pandemic is defined by ever-changing factors which artificial intelligence needs to cope with. To be useful in the clinic, a prediction model should make accurate prediction regardless of hospital location, viral variants or vaccination and immunity statuses. It should also be able to adapt its output to the level of resources available in a hospital at any given time. Finally, these tools need to seamlessly integrate into clinical workflows to not burden clinicians. In response, Klén et al. built CODOP, a freely available prediction algorithm that calculates the death risk of patients hospitalized with COVID-19 (https://gomezvarelalab.em.mpg.de/codop/). This model was designed based on biochemical data from routine blood analyses of COVID-19 patients. Crucially, the dataset included 30,000 individuals from 150 hospitals in Spain, the United States, Honduras, Bolivia and Argentina, sampled between March 2020 and February 2022 and carrying most of the main COVID-19 variants (from the original Wuhan version to Omicron). CODOP can predict the death or survival of hospitalized patients with high accuracy up to nine days before the clinical outcome occurs. These forecasting abilities are preserved independently of vaccination status or viral variant. The next step is to tailor the model to the current pandemic situation, which features increasing numbers of infected people as well as accumulating immune protection in the overall population. Further development will refine CODOP so that the algorithm can detect who will need hospitalisation in the next 24 hours, and who will need admission in intensive care in the next two days. Equipping primary care settings and hospitals with these tools will help to restore previous standards of health care during the upcoming waves of infections, particularly in countries with limited resources.


Subject(s)
COVID-19 , SARS-CoV-2 , Hospitalization , Hospitals , Humans , Machine Learning , Retrospective Studies
19.
Pharmaceuticals (Basel) ; 15(4)2022 Apr 13.
Article in English | MEDLINE | ID: covidwho-1810072

ABSTRACT

Organic peroxides are an important class of compounds for organic synthesis, pharmacological chemistry, materials science, and the polymer industry. Here, for the first time, we summarize the main achievements in the synthesis of organic peroxides by the action of Lewis acids and heteropoly acids. This review consists of three parts: (1) metal-based Lewis acids in the synthesis of organic peroxides; (2) the synthesis of organic peroxides promoted by non-metal-based Lewis acids; and (3) the application of heteropoly acids in the synthesis of organic peroxides. The information covered in this review will be useful for specialists in the field of organic synthesis, reactions and processes of oxygen-containing compounds, catalysis, pharmaceuticals, and materials engineering.

20.
Psychology in Russia: State of the Art ; 13(4):55-74, 2020.
Article in English | APA PsycInfo | ID: covidwho-1726796

ABSTRACT

Background: The COVID-19 pandemic has subjected people around the world to severe stress, evoking a variety of coping responses. Coping responses can be broadly classified into four strategies: 1) problem-focused coping;2) emotion focused coping;3) socially supported coping;and 4) avoidance. While there is a wide variability of individual coping responses, to some extent they are also culturally specific. Objective: This study aimed to compare the differences in the prevalence and factor structure of coping responses during COVID-19 pandemic in three countries: Russia, Kyrgyzstan, and Peru. Design: The sample included 501 participants from Russia, 456 participants from Kyrgyzstan, and 354 participants from Peru. The mean age of participants was 28 years in Russia (SD = 13.5);24 years in Kyrgyzstan (SD = 10.0);and 30 years in Peru (SD = 12.3). In Russia and Kyrgyzstan, coping strategies were assessed with an abbreviated Russian adaptation of the COPE (Coping Orientations to Problems Experienced) questionnaire. In Peru, coping responses were assessed using the Spanish version of the Brief COPE questionnaire. The average scores from fifteen COPE scales were used as the input data for linear modelling and factor analysis. Results: The coping scores varied substantially within each country. Differences between countries accounted for 17.7% of the total variability in religious coping;15.8% in acceptance;13.9% in mental disengagement;and less than 7% in the other coping strategies. No difference in the prevalence of coping responses was found between Russian and Kyrgyz participants after accounting for age and gender. In all three countries the coping responses were associated with the same four coping domains: problem-focused coping, socially supported coping, avoidance, and emotion-focused coping. Four factors explained up to 44% of the total variation in the COPE scores. Religious coping and mental disengagement were classified into different coping domains in the three countries. Conclusion: The results suggest that during the COVID-19 pandemic, people from different countries apply the full range of coping responses within the four universal coping strategies. Religious coping and mental disengagement differed the most across the countries, suggesting that some coping behaviors can take on different roles within the system of coping responses to stressful events. We attribute these differences to differing cultural and socioeconomic characteristics, and the different measures taken by governments in response to COVID-19. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

SELECTION OF CITATIONS
SEARCH DETAIL